There is growing appreciation that mechanical signals can be as important as chemical and electrical signals in biology. To include such signals in a systems biology description for understanding pathobiology and developing therapies, quantitative experiments on how solution phase and surface chemistry together produce biologically relevant mechanical signals are needed. Due to the appearance of drug-resistance hospital "superbugs", a system of large current interest is the destruction of bacteria by antibiotics forming bound drug/target complexes which stress the bacterial cell membranes. Here we use nanomechanical cantilevers as surface stress sensors together with equilibrium theory to describe quantitatively the mechanical response of a surface receptor to different antibiotics in the presence of competing ligands in solution. The antibiotics examined are the standard, FDA approved drug of last resort, vancomycin, as well as yet-to-be approved oritavancin, which shows promise for controlling vancomycin resistant infections. The work reveals variations among strong and weak competing ligands, such as proteins in human serum, which determine dosages in drug therapies. These findings further enhance our understanding of the biophysical mode of action of the antibiotics and will help develop better treatments, including choice of drugs as well as dosages, against pathogens. Serum proteins bind to drugs in blood and in so doing reduce the free concentration of active drug and its penetration into cell tissues. Accordingly, a drug that is bound to blood serum is no longer available to target the pathogenic organisms and so it is antibacterially inactive.
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Thus, quantifying active free drug concentrations in comparison to the total inhibitory concentration administered is important for determining the correct and safe patient dosage.
Furthermore, understanding the full impact of competitive ligands on the activity of selective inhibitors is important for the design of effective drug molecules to control infections as well as for determining dose levels. Even so, we are unaware of experiments exploring how interactions between competing inhibitory ligands and drug molecules can alter the mechanical properties of surface bound receptors to regulate the efficacy of drugs.
Here we describe a new methodology to monitor the interactions of molecules in solution and their impact on the surface mechanics of receptors to evaluate drug action in a competitive environment. We formulate a mathematical model to quantify surface stress changes where the reactions are occurring in solution and at the surfaces (Fig. 1) . As depicted in Figure 1 further enhanced by the passivation of the "bottom" surface of the cantilevers using PEG-
silane (Supplementary information).

Impact of Weak Competing Ligands on the Efficacy of Drugs
Serum proteins, a vital component of plasma in the transport of drugs, lipids or steroid hormones bind weakly to antibiotics 21 and display strong inhibitory effects 4,5 and therefore serve as a good model for investigating the impact of weak competing ligands. Figure 2 shows the differential bending signals obtained after injection of blood serum and Polysorbate 80 (PS80) 22 , as well as after injection of 3 μM Van and 0.5 μM Ori. Remarkably, antibiotics were detected even in 98% whole blood serum ( Fig. 2b and c) . The increasing noise with serum concentrations observed in our measurements was probably caused by the scattering of the laser light by serum proteins. Furthermore, as the serum concentration increases, the differential stress signals decrease because of the binding of drug molecules to blood serum. The cantilever deflection signal is proportional to the quantity of active free drug in the physiological medium, so the bending response is a measure of the effectiveness of dosage and correspondingly, a realistic in-vitro susceptibility test for the drugs. We thus can directly quantitate mechanically the effectiveness of dosages without prior amplification steps (for example FPIA). For this purpose, our approach unambiguously identifies the deflections caused by specific interactions between drugs in blood serum and the surface receptors yielding the first experimental evidence that drug-serum complexes only reduce surface stress (Fig. 2b-c) .
In pharmacology, the potency of drugs is often quoted as IC 50 , the concentration of antagonist that gives rise to 50% inhibition of the activity of a selective inhibitor 23 . To quantify the IC 50 of drug-serum interactions, a wider range of serum concentrations in the presence of all antibiotics were investigated and the results of the equilibrium differential surface stress summarised in Figure 2d . Equation (1) 
where σ eq corresponds to equilibrium surface stress, σ min is the constant of proportionality which corresponds to the minimum surface stress generated by a selective inhibitor (ligand 1 )
in the presence of large excess of the concentration of competitive ligand (ligand 2 ) and σ max is the constant of proportionality which corresponds to the maximum surface stress generated by ligand 1 in the absence of ligand 2 . The analysis shown in Figure 2d and in Table S1 is the outcome of the fit of equation (1) Figure 3 shows the outcome of drugtarget binding interactions in the presence of Ac-VSR. Our measurements reveal that for 500 µM competing ligand concentration, the interactions of all antibiotics at a surface were ∼ 40% inhibited despite having intial doses differing by a factor of 500. The equilibrium surface stress at each antibiotic concentration was measured on at least 4 arrays, and the resulting stress data sets were then modeled by equation (1), yielding IC 50 of 110 ± 10 μM for
Van and 400 ± 70 μM for Ori respectively. The enhanced IC 50 values observed in the presence of analogous competing ligand to the surface receptor is not surprising given that in a whole bacteria assay, a large amount of inhibitory ligand 24 is required to induce complete loss of activity (Supplementary Table S2 ). Figure 4 shows that for lower antibiotic concentrations (100 pM -0.1 µM), particularly of oritavancin, 50 -60 min was required to reach thermodynamic pseudo-equilibrium. In contrast, for higher antibiotic concentrations (0.5 µM -10 µM), equilibrium was reached in just under 3 minutes. Our experiments show that cantilever detection sensitivity is governed to a large extent by the degree of the affinity/avidity of the receptor-ligand interactions. For example, for the antibiotic drug vancomycin, which binds predominantly as a monomer, the minimum cantilever-detectable drug concentration is 10 nM 15 . This is 30 times more sensitive than established approaches such as the commercially available SPR method, for which the detection of 300 nM vancomycin has been reported (Table 1) . To demonstrate the ultimate sensitivity and to provide the evidence for our hypothesis that affinity/avidity determines detection sensitivity, we measured the binding of oritavancin, a novel antibiotic, against the same surface capture receptor as vancomycin. The data reveal a detection sensitivity of 100 pM antibiotic concentration in buffer (Fig. 4) , which is two orders of magnitude lower than for vancomycin 15 . 
where σ 1 corresponds to surface stress, n is the stoichiometric coefficient of the reactions without a competing soluble ligand and K 1 is the surface thermodynamic equilibrium dissociation constant. It is raised to the power n to ensure that K 1 maintains the dimension of concentration as n varies. Setting n = 1 yields the Langmuir isotherm where the reactions occur independently, while n > 1 corresponds to positive co-operative interactions and n < 1 is a measure of negative co-operativity. While equation (2) 
where σ 2 corresponds to surface stress in the presence of competing ligands and K 3 is the solution thermodynamic equilibrium dissociation constant. Eq. The difference between models (I) and (II) is that in the latter case we account for the concentration of free drug molecules in a physiological medium which governs their activity via competitive serum. Accordingly, we modeled our stress data using equation (3) as a description of ligand-receptor interactions to quantify simultaneous surface and solution reactions. The resulting analysis allows us to evaluate the impact of serum binding on the concentration of active free drugs ( Fig. 5c & d) . The parameters σ max , m, K 1 and K 3 , which characterise the surface mechanics and solution matrix are coupled in a statistical sense.
Therefore, to determine K 3 , we first carried out a nonlinear least-square best fit of equation (3) to the antibiotic stress data from phosphate buffer, i.e. in the absence of serum proteins.
This was achieved by setting [ligand 2 ] = 0. The maximum surface stress signals, σ max generated by Van and Ori were found to be 27 ± 3 mN/m and 36.8 ± 3.8 mN/m respectively.
The K 1 in phosphate buffer was calculated as 0.5 ± 0.2 µM for Van and 0.04 ± 0.1 µM for Ori while the stoichiometric coefficients values were n = 1 for Van and n = 1.2 ± 0.2 for Ori respectively. These binding constants from the cantilever measurements are in good agreement with other sensor methods, for example SPR (Table 1) .
Inspection of the denominator of Eq. (3) shows that the effect of serum on the nanomechanics of surface drug-target interactions is entirely via the term (K 1 /K 3 ) [serum] ; in this case ligand 2 = serum. We therefore repeated the process of least-square best fits of Eq. (3) to the antibiotic stress data in the presence of serum proteins, where the parameters σ max , n, and K 1 were fixed to their respective values in phosphate buffer while the serum concentration was fixed at ∼98%. The K 3 for Van binding to serum proteins in solution was found to be 500 ± 90 µM, 2000 times weaker than for Ori where K 3 is 30 ± 6 µM. Supplementary Table S1 shows a summary of K 3 for solution phase interactions via equations (1) and (4) Table S2 ) demonstrates convincingly that surface mechanics is strongly linked to the efficacy of drugs.
Novel Interactions of Bound Complexes in Solvents with Surface Receptors
For serum in solution, the agreement of cantilever data over the full range of antibiotic and serum concentrations with Eq. (3) indicates the validity of the model in Fig. 1b The experiments demonstrate that distinct changes of surface mechanics are drug-specific and that the solvent matrix plays a fundamental role in modulating the surface mechanics via straightforward inhibition due to competitive binding. It is clear that direct mechanical quantitation of the effectiveness of dosages using equation (3) without prior amplification steps will lead to progress in pharmacology and new insights into optimal clinical regimes, such as combination therapies. The experiments provide a blueprint for further studies to determine the role of chemistry and mechanics in membrane-bound receptors and proteins, which in turn will lead to the design of both better drugs as well as diagnostic platforms based on surface sensing layers. Perhaps the most obvious diagnostic application is to measure the active free drug availability in blood for a particular medical target and thereby determine appropriate doses tailored for individualised patients. With suitably engineered surface probes such as miniaturised cantilever arrays in a flow-through geometry, the diagnostic device would be paired with customised drug delivery for anaesthesia, anti-cancer, anti-HIV and antibacterial therapies. Anal. Biochem. 190, 66-70 (1990) . (12 
Additional Information
METHODS
Specificity of drug-target interactions.
A strategy of passivation of the 'bottom' side and inline referencing against a control cantilever was adopted to ensure measurements of drugtarget interactions resulted in specific signals only.
Experimental errors. The surface stress data error bars in each set of measurements were determined as the standard deviation of the surface stress data fitted measurements from four separate cantilever chips. observed to interact with the surface bound receptors to induce the stress, driving the enhanced efficacy of surface binding affinity for antibiotics (Fig. 1b) . Thus, our results show that in contrast to large-sized competing serum proteins, the pathways labeled by K 2 and K 4 in n/a SPR value not available Table 1 The detection sensitivity of drug-target interactions on cantilever arrays compared with the SPR measurements. (1) for K 1 = 0.04 ± 0.1 µM (solid lines, black) and for K 1 = (9.6 ± 2.4) x 10 -4 µM (dotted lines, orange). The surface stress data error bars were determined as the standard deviation of the surface stress data fitted measurements from four separate cantilever chips.
Role
Figure 4:
Investigating the mechanics of drug-target interactions using cantilever sensor arrays. The differential bending signals in buffer for VSR signals of 0.1, 10, 50, 100 and 500 nM Ori respectively. The differential PEG reference signal is shown (PEG 2 -PEG 1 black). The downward bending signal corresponds to a compressive (repulsive) surface stress and the minimum detectable drug concentration is 100 pM, showing that the cantilever differential bending signal scales with the drug load. The greyed-out area represents the injection of phosphate buffer solution without the drug for control measurement lasting for 10 mins to establish a baseline. and K 1 were fixed to their respective values in phosphate buffer while the serum concentration was fixed at ∼98% to calculate K 3 .The surface stress data error bars were determined as the standard deviation of the surface stress data fitted measurements from four separate cantilever chips.
